Table. Patient characteristics at enrolment Bempedoic acid for LDL-cholesterol management in patients with and Diabetes (n=647) Pre-diabetes (n=564) Normoglycaemia (n=1836) without diabetes: Insights from the MILOS study Age, years, mean (SD) Male, n (%)...
More
Table. Patient characteristics at enrolment Bempedoic acid for LDL-cholesterol management in patients with and Diabetes (n=647) Pre-diabetes (n=564) Normoglycaemia (n=1836) without diabetes: Insights from the MILOS study Age, years, mean (SD) Male, n (%) 67.4 (9.4) 390 (60.3) 65.5 (9.7) 343 (60.8) 64.9 (10.8) 1071 (58.3) Thomas Stulnig,1 Maurizio Averna,2,3 Ioanna Gouni-Berthold,4 Johan Wouter Jukema,5 Konstantinos Koskinas,6 Richa Chhabra,7 Katharina Wenz-Pöschl,7 Michael Tracy,7 Body mass index, kg/m2, mean (SD)a 29.0 (5.0) 27.3 (4.5) 26.7 (4.2) Hypertension, n (%)b 527 (81.5) 389 (69.0) 1179 (64.2) Mathias Lamparter,7 Jeanine E. Roeters van Lennep,8 Thomas Vanassche,9 Xavier Pintó,10 Kausik K. Ray,11 and Klaus G Parhofer12 on behalf of the MILOS study group HeFH, n (%)c 35 (5.4) 83 (14.7) 236 (12.9) 1Department of Medicine III and Karl Landsteiner Institute for Metabolic Diseases and Nephrology, Clinic Hietzing, Vienna, Austria; 2Department ProMISE – Department of Health Promotion,
Less
